Pfizer plans on sweetening offer for obesity drugmaker Metsera, source says
By Sabrina Valle and Tom Hals (Reuters) -Pfizer plans to sweeten its bid for Metsera, a person familiar with the matter told Reuters, after a judge denied its request to block rival drugmaker Novo Nordisk’s $10 billion offer for the biotech company. Pfizer is racing against the clock to salvage its takeover of Metsera, after…
